Omada Health, Inc. (OMDA)
NASDAQ: OMDA · Real-Time Price · USD
16.22
-0.30 (-1.82%)
May 21, 2026, 10:08 AM EDT - Market open
Omada Health Stock Forecast
Stock Price Forecast
According to 12 analysts polled by S&P Global, Omada Health stock has a consensus rating of "Buy" and an average price target of $23. The average 1-year stock price forecast is 41.80% higher than the current stock price, while the lowest is $15 (-7.52%) and the highest is $30 (+84.96%).
Price Target: $23 (+41.80%)
Analyst Consensus: Buy
Analyst Ratings
The average analyst rating for Omada Health stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 3 | 3 | 3 | 3 | 3 | 3 |
| Buy | 5 | 5 | 5 | 5 | 6 | 6 |
| Hold | 1 | 2 | 2 | 2 | 2 | 2 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 9 | 10 | 10 | 10 | 11 | 11 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Barclays | Barclays | Buy Maintains $18 → $20 | Buy | Maintains | $18 → $20 | +23.30% | May 8, 2026 |
| Citizens | Citizens | Buy Maintains $18 → $21 | Buy | Maintains | $18 → $21 | +29.47% | May 8, 2026 |
| Evercore ISI Group | Evercore ISI Group | Buy Maintains $15 → $20 | Buy | Maintains | $15 → $20 | +23.30% | May 8, 2026 |
| Wells Fargo | Wells Fargo | Hold Maintains $17 → $18 | Hold | Maintains | $17 → $18 | +10.97% | May 8, 2026 |
| Needham | Needham | Strong Buy Reiterates $28 | Strong Buy | Reiterates | $28 | +72.63% | May 8, 2026 |
Financial Forecast
Revenue This Year
325.17M
from 260.21M
Increased by 24.96%
Revenue Next Year
390.18M
from 325.17M
Increased by 19.99%
EPS This Year
0.06
from -0.35
EPS Next Year
0.25
from 0.06
Increased by 297.22%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 339.2M | 412.3M | |||
| Avg | 325.2M | 390.2M | |||
| Low | 310.0M | 367.1M |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 30.3% | 26.8% | |||
| Avg | 25.0% | 20.0% | |||
| Low | 19.1% | 12.9% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | 0.23 | 0.47 | |
| Avg | 0.06 | 0.25 | |
| Low | -0.19 | -0.07 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 |
|---|---|---|---|
| High | - | 662.2% | |
| Avg | - | 297.2% | |
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.